Mengna Wang
Department Of Otorhinolaryngology Head And Neck Surgery
Chongqing, China
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Noninvasive Characterization of Tumor Heterogeneity in HNSCC: From Clinical Utility to Biological Correlates.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 30, 2026
SPP1 promotes lymph node metastasis and malignant progression of head and neck squamous cell carcinoma by activating FAK-AKT signaling pathway.
Journal: World journal of surgical oncology
Published: January 29, 2026
Is Bilateral Neck Dissection Always Necessary for Hypopharyngeal Squamous Cell Carcinoma? Risk Factors for Occult Contralateral Metastasis.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: October 28, 2025
Lysophosphatidylcholine acyltransferase 1 promotes head and neck squamous cell carcinoma progression by enhancing COX17-dependent oxidative phosphorylation.
Journal: Cell death discovery
Published: September 08, 2025
TBC1D14 inhibits ribosome biogenesis to reduce lymph node metastasis in head and neck squamous cell carcinoma by mediating DDX31 ubiquitination.
Journal: International journal of biological macromolecules
Published: June 22, 2025
IGF2BP1 promotes the progression of head and neck squamous cell carcinoma by activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition.
Journal: World journal of surgical oncology
Published: March 19, 2025
ADAM22 enhances lymphatic metastasis and epithelial-mesenchymal transition in head and neck squamous cell carcinoma cells through integrin signaling.
Journal: Medical oncology (Northwood, London, England)
Published: January 19, 2025
Bilateral Neck Dissection in cN0 Supraglottic Squamous Cell Carcinoma: Essential or Not?
Journal: Head & neck
Published: October 28, 2024
Tumor Microenvironment-Responsive Nanoparticles Enhance IDO1 Blockade Immunotherapy by Remodeling Metabolic Immunosuppression.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: May 28, 2024
Last Updated: 09/26/2026